Screening of mortality in transplant patients using an assay for immune function.

@article{Berglund2011ScreeningOM,
  title={Screening of mortality in transplant patients using an assay for immune function.},
  author={David Berglund and Mats Bengtsson and Alireza Biglarnia and Erik Berglund and Shinji Yamamoto and Bengt von Zur-M{\"u}hlen and Tomas Lorant and Gunnar Tufveson},
  journal={Transplant immunology},
  year={2011},
  volume={24 4},
  pages={246-50}
}
BACKGROUND So far, the ImmuKnow Immune Cell Function Assay (Cylex, Inc., Columbia, MD, USA) has been used to assess risks of infection and rejection in transplant patients. We hypothesized that the ImmuKnow assay might be used for mortality screening in transplant patients overall. METHODS In the period of February 2007 to December 2009, at the Uppsala University Hospital, 362 patients who received either kidney, kidney+pancreas, kidney+islet cells, liver or liver+kidney allografts were… CONTINUE READING